Explainer

What Is Central Nervous System Depression? Causes and Risks

CNS depression is a slowdown of brain activity, usually from sedatives, opioids or alcohol. In 2025, 4.2 million Americans misused tranquilizers or sedatives.

Mental Health Stats Research Team 8 min read

Key Takeaways

  • Central nervous system (CNS) depression is a slowdown of brain activity caused by depressant drugs such as benzodiazepines, sleep medications and barbiturates[1], and by alcohol and opioids[7]. It is not the mood disorder called depression[3].Not a mood disorder[1]
  • Effects run from drowsiness, slurred speech and poor coordination to slowed breathing, and the most severe state of decreased alertness is coma[4][2].Drowsy to coma[4]
  • In 2025, 1.5% of Americans aged 12 or older, or 4.2 million people, misused prescription tranquilizers or sedatives in the past year, down from 1.7% (4.8 million) in 2021[5].4.2 million[5]
  • Alprazolam was involved in 4,642 U.S. overdose deaths in 2023, and 68.4% of those deaths also involved fentanyl[9].68.4%[9]
  • In 2016 the FDA required class-wide labeling changes for opioids and benzodiazepines about combined use, citing extreme sleepiness, respiratory depression, coma and death[6].2016[6]
If someone cannot be woken up or is breathing slowly: call 911, give naloxone if it is available, try to keep the person awake and breathing, lay them on their side to prevent choking, and stay with them until help arrives[11]. For emotional support or a mental health crisis, call or text 988.

What Is Central Nervous System Depression?

Central nervous system depression is a state in which brain and spinal cord activity slows, lowering alertness and, at higher levels, the drive to breathe. The term comes from pharmacology: CNS depressants, a category that includes tranquilizers, sedatives and hypnotics, are substances that can slow brain activity[1].

The word "depression" here describes reduced activity, not mood. It is unrelated to depression the mental health condition, which the National Institute of Mental Health describes as an illness that affects how a person feels, thinks and handles daily activities[3].

Most CNS depressants act by increasing activity at receptors for gamma-aminobutyric acid (GABA), the brain's main inhibitory neurotransmitter. That added inhibition produces the drowsy or calming effect that makes these drugs useful for anxiety and sleep disorders[1].

Mild CNS depression is often the intended effect of a medicine. Deeper CNS depression, where a person cannot stay awake or breathes too slowly, is a medical emergency. MedlinePlus lists stupor, obtundation and unresponsiveness as alternative names for decreased alertness, with coma as its most severe form[2].

CNS depressant

A drug that slows brain activity. The National Institute on Drug Abuse groups tranquilizers, sedatives and hypnotics in this category, including benzodiazepines, non-benzodiazepine sleep medicines (z-drugs) and barbiturates[1]. Alcohol and opioids also suppress the brain areas that control breathing[7].

Related Terms

sedative-hypnotics
tranquilizers
downers
respiratory depression
decreased alertness

Source: National Institute on Drug Abuse; NIAAA

Is CNS Depression the Same as Clinical Depression?

No. Clinical depression, also called major depressive disorder, is a mood disorder in which genetic, biological, environmental and psychological factors play a role[3]. It is diagnosed from a pattern of symptoms, described in our guide to the DSM-5 depression criteria.

CNS depression is a physical state of reduced brain activity. When a drug is the cause, it typically eases as the drug wears off or is reversed, while major depression is a persistent mood illness.

The two can meet in practice. Some medicines used to treat depression and psychosis can cause decreased alertness as a side effect[2], and benzodiazepines are prescribed for anxiety, acute stress reactions and panic attacks[1]. How often anxiety and depression overlap is covered in our explainer on depression and anxiety.

A closely related term, respiratory depression, refers specifically to breathing that is too slow or shallow. It is one of the most dangerous consequences of deep CNS depression.

What Causes CNS Depression? Drugs and Medical Conditions

Medicines and other substances

Prescription CNS depressants fall into three main groups. Benzodiazepines such as diazepam, clonazepam and alprazolam treat anxiety and panic; z-drugs such as zolpidem, eszopiclone and zaleplon act on the same GABA type A receptors; and barbiturates such as phenobarbital are now used less often because they carry a higher overdose risk than benzodiazepines[1].

The DEA's depressant category also includes meprobamate, methaqualone and the illicit drug GHB[4]. Federal survey definitions count prescription muscle relaxants among tranquilizers[5].

Alcohol is also a depressant. At high blood levels, areas of the brain that control breathing, heart rate and temperature begin to shut down[7]. Opioid pain relievers such as oxycodone and morphine, and illicit opioids such as heroin, suppress the same vital-function areas[7].

The FDA has also warned that gabapentin and pregabalin can cause serious breathing problems in people with respiratory risk factors, including use of opioids and other CNS depressants, lung disease such as COPD, and older age[8]. Over-the-counter sleep aids are covered in our guide to sleeping pills.

Medical causes

Reduced alertness does not always come from a drug. MedlinePlus lists chronic kidney disease, high or low blood sugar, abnormal blood sodium, liver failure, severe infection, thyroid disorders, head trauma, stroke, seizures, low oxygen, very low body temperature and severe lung or heart disease as possible causes[2]. Exposure to heavy metals, hydrocarbons or toxic gases can also produce it[2].

Common CNS Depressants by Drug Class

Drug classExamplesMain medical usesKey safety note
BenzodiazepinesAlprazolam, clonazepam, diazepam, lorazepamAnxiety, panic, seizures, short-term insomniaBoxed warning on misuse, dependence, withdrawal
Z-drugsZolpidem, eszopiclone, zaleplonShort-term insomniaAct on the same receptors as benzodiazepines
BarbituratesPhenobarbital, butalbital, pentobarbitalSeizures, surgeryHigher overdose risk than benzodiazepines
OpioidsOxycodone, morphine, heroin, fentanylPain (prescription forms)FDA combined-use warning, 2016
GabapentinoidsGabapentin, pregabalinPrescription medicinesFDA breathing warning, 2019
AlcoholBeer, wine, spiritsNot a medicineRaises overdose risk with sedatives and opioids

Major groups of drugs that slow central nervous system activity, with examples named by NIDA, the DEA and the FDA[1][4].

1Benzodiazepine boxed warning updated in 2020[10]; opioid and benzodiazepine combination warning issued in 2016[6]; gabapentinoid breathing warning issued in 2019[8].

2The table lists common examples, not every CNS depressant.

Sources

  • •NIDA, 2023
  • •DEA, 2025
  • •FDA, 2016, 2019, 2020

Signs and Symptoms of CNS Depression, From Mild to Severe

In the first few days on a depressant, people usually feel sleepy and uncoordinated, and those effects fade as tolerance develops[1]. The DEA lists slurred speech, loss of motor coordination, weakness, dizziness, blurred vision, nausea, low blood pressure and slowed breathing as unwanted physical effects[4].

Mental effects include amnesia for events while under the influence, slower reaction time, impaired judgment and confusion[4].

Signs that CNS depression has become dangerous include:

  • Unconsciousness or inability to wake up[11]
  • Slow, shallow or difficult breathing, including choking, gurgling or snoring sounds in someone who cannot be woken[11]
  • Fewer than 8 breaths per minute, or 10 seconds or more between breaths, in alcohol overdose[7]
  • Slow heart rate, clammy skin, no gag reflex, and bluish or pale skin[7]
  • Pinpoint pupils that do not react to light, a sign that opioids are involved[11]

MedlinePlus advises getting medical help for any decrease in consciousness, including one caused by alcohol intoxication[2].

Why Combining CNS Depressants Is So Dangerous

Depressants add to each other's effects. In 2016 the FDA required class-wide labeling changes for opioids and benzodiazepines, warning that combined use with each other or with other CNS depressants, including alcohol, can cause extreme sleepiness, slowed or difficult breathing, coma and death[6].

NIAAA states that taking alcohol with opioids, sleep aids such as zolpidem, or benzodiazepines such as alprazolam intensifies each drug's effects and can produce an overdose with even moderate amounts of alcohol[7].

The DEA notes that large doses of benzodiazepines alone are rarely fatal, unlike barbiturates, unless they are combined with other drugs or alcohol[4]. Death certificate data reflect this pattern: in 2023, 68.4% of overdose deaths involving alprazolam and 59.3% of those involving gabapentin also involved fentanyl[9].

More on how alcohol acts on the brain is in our explainer on how alcohol affects the brain.

People aged 12 or older who misused prescription tranquilizers or sedatives in the past year, U.S., 2025
4.2 million

That is 1.5% of the population aged 12 or older, down from 1.7% (4.8 million) in 2021. The figure counts misuse only, not use as prescribed.

"1.5 percent (or 4.2 million people) in 2025"

Substance Abuse and Mental Health Services Administration(2026) View Source

How Many People Are Exposed to CNS Depressants?

Prescription use is common. In 2019, an estimated 92 million benzodiazepine prescriptions were dispensed from U.S. outpatient retail and mail-order pharmacies, with alprazolam (38%), clonazepam (24%) and lorazepam (20%) the most frequent[10].

Misuse is smaller but measurable. The 2025 National Survey on Drug Use and Health found that 4.2 million people aged 12 or older misused prescription tranquilizers or sedatives in the past year[5]. Among young adults aged 18 to 25, the rate fell from 2.7% (916,000 people) in 2021 to 1.6% (582,000) in 2025[5].

Overdose deaths involving some depressants have moved in different directions. Deaths involving alprazolam fell from 6,699 in 2017 to 4,642 in 2023, while deaths involving gabapentin more than doubled, from 1,865 to 4,027[9]. Rates for clonazepam and diazepam did not change significantly over the period[9].

These counts reflect any mention of a drug on a death certificate, and a death involving several drugs is counted under each one[9]. For the number of people with a diagnosable disorder, see our pages on substance use disorder and opioid use disorder.

U.S. Overdose Deaths Involving Selected CNS Depressants, 2017 vs. 2023

DrugClassDeaths, 2017Deaths, 2023Rate per 100,000, 2023
AlprazolamBenzodiazepine6,6994,6421.4
GabapentinGabapentinoid1,8654,0271.2
ClonazepamBenzodiazepine2,0831,9760.6
DiazepamBenzodiazepine2,2791,6880.5
OxycodoneOpioid6,0944,1421.2

Drug overdose deaths in which each drug was mentioned on the death certificate, United States, with 2023 age-adjusted rates[9].

1Deaths involving more than one drug are counted under each drug, so rows overlap and cannot be added.

2Reporting of at least one specific drug on death certificates improved from 88% of overdose deaths in 2017 to 96% in 2023, which affects comparisons across years[9].

Sources

  • •NCHS, National Vital Statistics Reports, 2026

Tolerance, Dependence and Withdrawal

With long-term use, people may need larger doses of a depressant to get the same effect, and continued use can lead to dependence and withdrawal when use is cut back or stopped[1]. Because these drugs slow brain activity, stopping them can cause a rebound effect that includes seizures[1].

The FDA's 2020 boxed warning states that physical dependence can occur when benzodiazepines are taken steadily for several days to weeks, even as prescribed, and that stopping abruptly or reducing the dose too quickly can cause withdrawal reactions, including seizures, that can be life-threatening[10]. The FDA advises a gradual taper when the dose is reduced or the drug is stopped[10].

NIDA notes that withdrawal from benzodiazepines is rarely life-threatening, whereas withdrawal after prolonged barbiturate use can have life-threatening complications[1]. Alcohol withdrawal is covered in our guide to signs of alcohol withdrawal and the alcohol use disorder page.

How CNS Depression Is Assessed and Treated

A person with decreased consciousness is usually evaluated in an emergency department. Clinicians examine the heart, breathing and nervous system and ask about medicines, alcohol and drug use, diabetes, seizures and recent head injury[2].

Tests can include pulse oximetry or blood gas, a toxicology panel and blood alcohol level, a metabolic panel and liver tests, an electrocardiogram, and a CT or MRI of the head[2]. Treatment depends on the cause, and the longer decreased alertness lasts, the worse the outcome tends to be[2].

For opioid-related CNS depression, naloxone can reverse the effects of an opioid overdose[11]. For other depressants and for medical causes, treatment is directed at the specific cause[2].

Flumazenil reverses benzodiazepines, but a meta-analysis of 13 randomized trials with 994 patients found serious adverse events were more common with flumazenil than placebo (12 of 498 vs. 2 of 492; risk ratio 3.81)[12]. The authors concluded it should not be used routinely in suspected benzodiazepine poisoning[12].

Frequently Asked Questions

Sources & References

  1. What classes of prescription drugs are commonly misused? Misuse of Prescription Drugs Research Report. National Institute on Drug Abuse. Published 2023. Accessed October 2026. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-classes-prescription-drugs-are-commonly-misused [Link]
  2. Decreased alertness. MedlinePlus Medical Encyclopedia, National Library of Medicine. Published 2025. Accessed October 2026. https://medlineplus.gov/ency/article/003202.htm [Link]
  3. Depression. National Institute of Mental Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/topics/depression [Link]
  4. Depressants. Drugs of Abuse: A DEA Resource Guide, 2024 Edition. U.S. Drug Enforcement Administration. Published 2025. Accessed October 2026. https://www.dea.gov/sites/default/files/2025-01/Depressants-2024-Drug-Fact-Sheet.pdf [Link]
  5. Key Substance Use and Mental Health Indicators in the United States: Results from the 2025 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. Published 2026. Accessed October 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt57150/2025-nsduh-annual-national-report.pdf [Link]
  6. New Safety Measures Announced for Opioid Analgesics, Prescription Opioid Cough Products, and Benzodiazepines. U.S. Food and Drug Administration. Published 2016. Accessed October 2026. https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and [Link]
  7. Understanding the Dangers of Alcohol Overdose. National Institute on Alcohol Abuse and Alcoholism. Accessed October 2026. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-dangers-of-alcohol-overdose [Link]
  8. Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug Safety Communication - Serious Breathing Problems. U.S. Food and Drug Administration. Published 2019. Accessed October 2026. https://www.fda.gov/safety/medical-product-safety-information/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication [Link]
  9. Garnett MF, Cisewski JA, Ahmad FB. Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017–2023. National Vital Statistics Reports, Vol. 75, No. 1. National Center for Health Statistics. Published 2026. Accessed October 2026. https://www.cdc.gov/nchs/data/nvsr/nvsr75/nvsr75-01.pdf [Link]
  10. FDA Requiring Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class. U.S. Food and Drug Administration. Published 2020. Accessed October 2026. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class [Link]
  11. What to Do If You Think Someone Is Overdosing. Centers for Disease Control and Prevention. Published 2024. Accessed October 2026. https://www.cdc.gov/stop-overdose/response/index.html [Link]
  12. Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication: A Systematic Review with Meta-Analyses of Randomised Trials. Basic & Clinical Pharmacology & Toxicology. Published 2016. Accessed October 2026. https://doi.org/10.1111/bcpt.12434 [Link]

Related Statistics